Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EG-HZ for Herpes Zoster Prevention in Healthy Adults
NCT04210752Phase 1Completed
- Sponsor
- EyeGene, Inc.
- Start
- Feb 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of EG-HZ in herpes zoster (HZ), sponsored by EyeGene, Inc. Started Feb 2020; status: completed.
02
Drugs
EG-HZ
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT04210752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04210752.